~ Strong start to the year with 1Q23 financial results ~ ~ Executing strategy to accelerate growth ~ PLANO, Texas, April 27, 2023 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for […]

~ Strong sales growth over last year of 19% in 4Q22 and 13% for the full year ~ ~ Expect 7% to 9% sales growth in 2023 with expanding margins ~ PLANO, Texas, Feb. 16, 2023 (GLOBE NEWSWIRE) — Integer […]

~ Strategic transaction to meaningfully reduce interest expense ~ ~ Immediately earnings accretive in 2023 ~ PLANO, Texas, Feb. 03, 2023 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR) (the “Company”), a leading medical device outsource manufacturer, announces the closing […]

~ Preliminary fourth quarter 2022 sales increase of 18% to 19% versus 2021 ~ ~ Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call ~ PLANO, Texas, Jan. 30, 2023 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: […]

~ 3Q22 results in line with October 5, 2022 preliminary view ~ ~ Growth strategy fundamentals remain strong ~ PLANO, Texas, Oct. 27, 2022 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results […]

PLANO, Texas, Oct. 05, 2022 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource manufacturer, provides a revised 2022 outlook and an update on the third quarter. Integer’s customer demand continues to be very strong from […]

~ 1Q22 sales and profit consistent with expectations ~ ~ 2022 outlook updated for Aran Biomedical acquisition ~ PLANO, Texas, April 28, 2022 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for […]